---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-26-000085"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2026-05-14T23:31:55+00:00"
generated_at: "2026-05-15T10:16:29.268565+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DexCom sets 10%+ annual organic revenue growth target through 2030; authorizes $1B share buyback

## Summary
- Long-range target: organic revenue growth 10%+ every year through 2030.
- 2030 non-GAAP gross profit margin target of 67-69%; operating margin 29-30%.
- 2030 adjusted EBITDA margin target of 36-37%.
- Board authorized $1.0B share repurchase program, expiring June 30, 2027.
- Prior $250M remaining buyback program terminated.

## SEC filing metadata
- accession: 0001093557-26-000085
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2026-05-14T23:31:55+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000085/0001093557-26-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000085/dxcm-20260514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-26-000085
- JSON: https://secwatch.observer/filing/0001093557-26-000085.json
- Plain text: https://secwatch.observer/filing/0001093557-26-000085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.